— Know what they know.
Not Investment Advice

MRSN NASDAQ

Mersana Therapeutics, Inc.
1W: -0.2% 1M: +5.5% 3M: +264.4% 1Y: -22.9% 3Y: -80.0% 5Y: -95.8%
$29.08
Last traded 2025-12-31 — delisted
NASDAQ · Healthcare · Biotechnology · $145.4M mcap · 4M float · 3.85% daily turnover · Short 38% of daily vol

Supply Chain Overview

2 relationships
0
As Filer
counterparties named
2
As Counterparty
mentioned by others
2025-11-13
Earliest Filing
2026-01-06
Latest Filing

Mentioned As Counterparty

2 mentions

Other companies that named MRSN in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
DAWN Day One Biopharmaceuticals, Inc. acquirer Target company acquired in a merger transaction. 2026-01-06 View
DAWN Day One Biopharmaceuticals, Inc. acquirer Target company in the merger agreement with Day One Biopharmaceuticals, Inc. 2025-11-13 View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms